Name:
Cinnarizine Sopharma tab 25mg in a blister pack No. 50×1
Description:
Cinnarizine is a drug from a group of medicines called calcium channel blockers. It improves microcirculation. Suppresses nystagmus (uncontrolled eye movements) and other manifestations of vestibular disorders, reduces the excitability of the labyrinth. It has an antihistamine (anti-allergic) effect. It is used for symptomatic treatment of diseases of the vestibular apparatus and Meniere’s disease, which is expressed in dizziness, nausea, vomiting, tinnitus; as well as for the prevention and treatment of road sickness. Contraindications Do not take the drug if you are allergic (hypersensitive) to the active substance or to one of the excipients of the drug; if you are pregnant or breastfeeding. orientation and balance); if you have hypotension (low blood pressure); if you have stomach disease. Cinnarizine should be used with caution in patients with hepatic or renal insufficiency. Cinnarizine Sopharma contains lactose as an excipient, which should be taken into account if you have intolerance to some sugars. Please talk to your doctor before taking this drug. Cinnarizine Sopharma contains wheat starch but is acceptable for use in patients with celiac disease. The drug should not be taken by patients with wheat allergy (other than celiac disease). Interaction with other medicinal products Tell your doctor or pharmacist if you are taking or have recently taken other medicines. Cinnarizine enhances the effect of antidepressants, drugs that depress the activity of the central nervous system, and alcohol. Due to the presence of an antihistamine effect, cinnarizine can affect the result in the anti-doping control of athletes (false positive result), as well as neutralize positive reactions during diagnostic skin tests (treatment should be canceled 4 days before the study). Taking Cinnarizine Sopharma with food and drink Do not drink alcoholic beverages during treatment with the drug. Pregnancy and breast-feeding Before using any medicine, ask your doctor or pharmacist for advice. Pregnancy Due to the lack of data on the clinical use of the drug in pregnant women, the use of the drug is contraindicated during pregnancy. Breastfeeding The use of the drug during breastfeeding is contraindicated. If treatment with the drug is necessary, breastfeeding should be discontinued. Driving vehicles and working with mechanisms Cinnarizine Sopharma can cause drowsiness, especially at the beginning of treatment, in the event of this effect, patients should not drive vehicles and work with moving mechanisms. Method of application and dosageFor oral administration. Vestibular symptoms (dizziness, nausea) Adults and children over 12 years old: 1 tablet 3 times a day. Recommended doses should not be exceeded. Kinetoses (“road sickness” or motion sickness) Adults and children over 12 years: 1 tablet 2 hours before travel and 1 tablet every 8 hours thereafter during travel. Take the tablets after meals with plenty of water at room temperature. Recommended doses should not be exceeded. Cinnarizine should be used with caution in patients with hepatic or renal insufficiency. If you have taken more than the prescribed dose of Cinnarizine Sopharma If you have taken more than the prescribed dose, contact your doctor or the nearest hospital. In case of an overdose, a decrease in blood pressure, trembling, nausea, and drowsiness are possible. If you miss a dose of Cinnarizine Sopharma If you miss a single dose, take it as soon as possible. If it’s time for your next dose, take it as usual. Do not use a double dose to make up for a missed one. Possible side effects Symptoms such as drowsiness and gastrointestinal disturbances may occur. They are usually transient and can be prevented by gradually reaching the optimal dose. In rare cases, headache, dry mouth, weight gain, excessive sweating and allergic reactions are observed. In very rare cases, the development of lichen planus and lupus-like symptoms have been reported. A single case of cholestatic jaundice has been reported. Rare cases of aggravation or development of extrapyramidal symptoms were noted mainly in the elderly with long-term treatment. Immune system disorders: hypersensitivity (allergic reactions). Nervous system disorders: drowsiness, headache, extrapyramidal disorders. Gastrointestinal disorders: dry mouth, gastrointestinal disorders. Liver and biliary tract disorders: cholestatic jaundice. Skin and subcutaneous tissue disorders: hyperhidrosis (excessive sweating), lichen planus. Musculoskeletal and connective tissue disorders: lupus-like symptoms. Laboratory indicators: increase in body weight. In the event of adverse reactions, including those not listed in this leaflet, stop using the drug and consult a doctor. Storage conditions Store in the original packaging, protected from moisture and light, at a temperature not exceeding 25 °C. Keep out of the reach of children. Do not use Cinnarizine Sopharma after the expiry date which is stated on the pack. The expiration date corresponds to the last day of the specified month. Medicines should not be disposed of in the sewer or in the household waste container. Ask your pharmacist how to dispose of medicines, if necessary. Such measures will contribute to the protection of the environment. Conditions for dispensing from the pharmacy chain By prescription. Composition 1 (one) tablet contains: Active substance: cinnarizine – 25 mg; Excipients: lactose monohydrate; wheat starch; povidone K 25; magnesium stearate; silicon dioxide colloidal anhydrous; cellulose microcrystalline (type 101). Packing Round biconvex tablets with a diameter of 7 mm, white or almost white, odorless. Primary packaging: 50 tablets in a hard orange transparent PVC/aluminum foil blister. Secondary packaging: 1 blister in a carton box with a leaflet for the consumer. Buy Cinnarizine Sopharma tablets 25mg No. 50×1 Price for Cinnarizine Sopharma tablets 25mg No. 50×1
Cinnarizine Sopharma tablets 25mg №50×1
$8.00
SKU: 11869
Category: Improvement of cerebral circulation
INN | cinnarizine |
---|---|
The code | 11 869 |
Barcode | 3 800 010 641 814 |
Dosage | 25mg |
Active substance | Cinnarizine |
Amount in a package | 10 |
Manufacturer | Sopharma OJSC, Bulgaria |
Importer | IOOO "Interfarmaks", Republic of Belarus, 223028, Minsk region, Minsk district, Zhdanovichsky s / s, ag. Zhdanovichi, st. Zvezdnaya, 19A-5, pom. 5-2 |
Be the first to review “Cinnarizine Sopharma tablets 25mg №50×1” Cancel reply
Related products
Improvement of cerebral circulation
$14.00
Improvement of cerebral circulation
$20.00
Reviews
There are no reviews yet.